280 related articles for article (PubMed ID: 21190577)
1. Eag and HERG potassium channels as novel therapeutic targets in cancer.
Asher V; Sowter H; Shaw R; Bali A; Khan R
World J Surg Oncol; 2010 Dec; 8():113. PubMed ID: 21190577
[TBL] [Abstract][Full Text] [Related]
2. The Eag potassium channel as a new prognostic marker in ovarian cancer.
Asher V; Khan R; Warren A; Shaw R; Schalkwyk GV; Bali A; Sowter HM
Diagn Pathol; 2010 Dec; 5():78. PubMed ID: 21138547
[TBL] [Abstract][Full Text] [Related]
3. Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels.
Clarke CE; Hill AP; Zhao J; Kondo M; Subbiah RN; Campbell TJ; Vandenberg JI
J Physiol; 2006 Jun; 573(Pt 2):291-304. PubMed ID: 16556651
[TBL] [Abstract][Full Text] [Related]
4. Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.
Herzberg IM; Trudeau MC; Robertson GA
J Physiol; 1998 Aug; 511 ( Pt 1)(Pt 1):3-14. PubMed ID: 9679158
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of potassium ion channels in human renal cell carcinoma.
Wadhwa S; Wadhwa P; Dinda AK; Gupta NP
Int Urol Nephrol; 2009; 41(2):251-7. PubMed ID: 18777199
[TBL] [Abstract][Full Text] [Related]
6. Differences between ion binding to eag and HERG voltage sensors contribute to differential regulation of activation and deactivation gating.
Lin MC; Papazian DM
Channels (Austin); 2007; 1(6):429-37. PubMed ID: 18690045
[TBL] [Abstract][Full Text] [Related]
7. The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells.
Shao XD; Wu KC; Hao ZM; Hong L; Zhang J; Fan DM
Cancer Biol Ther; 2005 Mar; 4(3):295-301. PubMed ID: 15846098
[TBL] [Abstract][Full Text] [Related]
8. Voltage-dependent activation in EAG channels follows a ligand-receptor rather than a mechanical-lever mechanism.
Malak OA; Gluhov GS; Grizel AV; Kudryashova KS; Sokolova OS; Loussouarn G
J Biol Chem; 2019 Apr; 294(16):6506-6521. PubMed ID: 30808709
[TBL] [Abstract][Full Text] [Related]
9. Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design.
Narayana Moorthy NS; Ramos MJ; Fernandes PA
Curr Drug Targets; 2013 Jan; 14(1):102-13. PubMed ID: 23061466
[TBL] [Abstract][Full Text] [Related]
10. State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy.
Ganapathi SB; Kester M; Elmslie KS
Am J Physiol Cell Physiol; 2009 Apr; 296(4):C701-10. PubMed ID: 19244476
[TBL] [Abstract][Full Text] [Related]
11. Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
Chen J; Seebohm G; Sanguinetti MC
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12461-6. PubMed ID: 12209010
[TBL] [Abstract][Full Text] [Related]
12. The eag family of K+ channels in Drosophila and mammals.
Ganetzky B; Robertson GA; Wilson GF; Trudeau MC; Titus SA
Ann N Y Acad Sci; 1999 Apr; 868():356-69. PubMed ID: 10414305
[TBL] [Abstract][Full Text] [Related]
13. HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential.
He S; Moutaoufik MT; Islam S; Persad A; Wu A; Aly KA; Fonge H; Babu M; Cayabyab FS
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188355. PubMed ID: 32135169
[TBL] [Abstract][Full Text] [Related]
14. Two mutations at different positions in the CNBH domain of the hERG channel accelerate deactivation and impair the interaction with the EAG domain.
Kume S; Shimomura T; Tateyama M; Kubo Y
J Physiol; 2018 Oct; 596(19):4629-4650. PubMed ID: 30086184
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
Guo J; Gang H; Zhang S
J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
[TBL] [Abstract][Full Text] [Related]
16. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an eag-like potassium channel in human neuroblastoma cells.
Meyer R; Heinemann SH
J Physiol; 1998 Apr; 508 ( Pt 1)(Pt 1):49-56. PubMed ID: 9490815
[TBL] [Abstract][Full Text] [Related]
18. Expression and role of hERG channels in cancer cells.
Arcangeli A
Novartis Found Symp; 2005; 266():225-32; discussion 232-4. PubMed ID: 16050271
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086
[TBL] [Abstract][Full Text] [Related]
20. Ether-à-go-go K
Bauer CK; Schwarz JR
J Physiol; 2018 Mar; 596(5):769-783. PubMed ID: 29333676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
